Durvalumab / Imfinzi Defies Expectations in MIBC, Offering Survival Gains Beyond Complete Response in NIAGARA Trial – ASCO GU 2025 ASCO GU 3 Mins Read Transforming MIBC Treatment: Insights from the NIAGARA TrialPosted on February 16, 2025The landscape of treating muscle-invasive bladder cancer (MIBC) has…
